Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Pharmacoepidemiology and Drug Safety|November 17, 2004
Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid programRobert J Cluxton, Zili Li, Pamela C Heaton, et al.Archives of Internal Medicine|June 24, 2009
The frequency of hyperkalemia and its significance in chronic kidney diseaseLisa M Einhorn, Min Zhan, Van Doren Hsu, et al.Pediatrics|December 2, 2009
Adherence feedback to improve asthma outcomes among inner-city children: a randomized trialMichiko Otsuki, Michelle N Eakin, Cynthia S Rand, et al.Archives of Pediatrics & Adolescent Medicine|June 7, 2006
Effectiveness of nebulizer use-targeted asthma education on underserved children with asthmaArlene M Butz, Mona G Tsoukleris, Michele Donithan, et al.Health Services Research|May 15, 2026
Sustained Impacts in the Oncology Care Model: Medicare Payment Impacts in the 18 Months After the Model's EndDerek Hoodin, Sean McClellan, Nadine Chami, et al.International Journal of Alzheimer'S Disease|June 8, 2010
Sensitivity of nursing home cost comparisons to method of dementia diagnosis ascertainmentAnn L Gruber-Baldini, Bruce Stuart, Ilene H Zuckerman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2022
Impact of the Oncology Care Model on Use of Supportive Care Medications During Cancer TreatmentGabriel A Brooks, Mary Beth Landrum, Nirav S Kapadia, et al.JAMA|March 25, 2026
The Oncology Care Model and Medicare Payments, Utilization, and QualityGabriel A Brooks, Matthew Trombley, Sean McClellan, et al.Journal of the American Heart Association|June 13, 2015
Intensive care units with low versus high volume of myocardial infarction: clinical outcomes, resource utilization, and quality metricsJoshua M Stolker, Omar Badawi, John A Spertus, et al.Journal of the National Cancer Institute|February 8, 2022
The Oncology Care Model and Adherence to Oral Cancer Drugs: A Difference-in-Differences AnalysisNancy L Keating, Gabriel A Brooks, Mary Beth Landrum, et al.Pageof 4